数字健康在房颤检测与管理中的作用
本文综述了用于检测房颤的移动健康设备(包括光电容积描记、单导联心电图及非接触式方法),讨论了大规模筛查的可行性与争议,并针对移动健康设备诊断的房颤患者及年轻患者的特殊考量给出了实用建议。
要点
- 移动健康设备使大规模房颤筛查可行,但筛查争议仍存。
- 消费者驱动的筛查在低危和高危人群中广泛发生。
- 医生需熟悉这些技术的风险与局限性并指导患者。
核心结论
- 移动健康设备使房颤大规模筛查可行且较常规护理检测更多病例,但筛查争议仍存。
- 年轻早期采用者增多可能使早发房颤患者需转诊至遗传性心律失常门诊。
研究设计与样本
- 综述,讨论用于检测房颤的移动健康设备及相关试验与临床建议。
主要发现
- 移动健康设备通过光电容积描记、单导联心电图及非接触式方法检测房颤。
- 大规模筛查较常规护理检测更多房颤病例,但即使在老年高危人群中筛查仍存争议。
- 年轻人占移动健康设备早期采用者很大部分,可能使更多早发房颤患者进入临床关注。
临床怎么用
- 医生应熟悉移动健康设备技术及其风险与局限性。
- 对移动健康设备诊断的房颤患者应给出实用建议。
- 年轻房颤患者需特殊考量,可能转诊至遗传性心律失常门诊。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Atrial fibrillation is a common arrhythmia associated with significant morbidity, mortality and decreased quality of life. Mobile health devices marketed directly to consumers capable of detecting atrial fibrillation through methods including photoplethysmography, single-lead ECG as well as contactless methods are becoming ubiquitous. Large-scale screening for atrial fibrillation is feasible and has been shown to detect more cases than usual care-however, controversy still exists surrounding screening even in older higher risk populations. Given widespread use of mobile health devices, consumer-driven screening is happening on a large scale in both low-risk and high-risk populations. Given that young people make up a large portion of early adopters of mobile health devices, there is the potential that many more patients with early onset atrial fibrillation will come to clinical attention requiring possible referral to genetic arrythmia clinic. Physicians need to be familiar with these technologies, and understand their risks, and limitations. In the current review, we discuss current mobile health devices used to detect atrial fibrillation, recent and upcoming trials using them for diagnosis of atrial fibrillation, practical recommendations for patients with atrial fibrillation diagnosed by a mobile health device and special consideration in young patients.
引用
- Tooley JE, Perez MV. Role of digital health in detection and management of atrial fibrillation. Heart. 2022. PMID: 34344729. doi:10.1136/heartjnl-2020-318262
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。